Medetomidine

DB11428ExperimentalVet approvedSmall molecule

Medetomidine is a synthetic compound used as a surgical anesthetic and analgesic. It is normally found as its hydrochloride salt, medetomidine hydrochloride. Medetomidine is an intravenously available alpha-2 adrenergic agonist.... The drug has been developed by Orion Pharma.

Chemical structure of Medetomidine
Formula / weight
C13H16N2 · 200.2795 g/mol (avg)

Resolves to

Compound
UNIIMR15E85MQMCAS86347-14-0ChEMBLCHEMBL77921ChEBI48552KEGGD08165
Clinical / RWD
RxNorm52016PharmGKBPA449256
Structure
InChIKeyCUHVIMMYOGQXCV-UHFFFAOYSA-NSMILESCC(C1=CN=CN1)C1=CC=CC(C)=C1C
Targets
P18825ADRA2CP35348ADRA1AP18089ADRA2BP25100ADRA1DP35368ADRA1BP08913ADRA2A

What you can answer from here — as of September 12, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,151Drug interactionsStructured to mechanism, not free text
Sign in
16+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Medetomidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In